Order Article Reprints

Zheng J-H, Yao H-F, Duan Z-H, Ji P-X, Yang J, Zhu Y-H, Jia Q-Y, Yang J-Y, Liu D-J, Sun Y-W, et al. Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma. Pharmaceuticals. 2022; 15(11):1336. https://doi.org/10.3390/ph15111336

Zheng, Jia-Hao, Hong-Fei Yao, Zong-Hao Duan, Pei-Xuan Ji, Jian Yang, Yu-Heng Zhu, Qin-Yuan Jia, Jian-Yu Yang, De-Jun Liu, Yong-Wei Sun, and et al. 2022. "Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma" Pharmaceuticals 15, no. 11: 1336. https://doi.org/10.3390/ph15111336

Zheng, J.-H., Yao, H.-F., Duan, Z.-H., Ji, P.-X., Yang, J., Zhu, Y.-H., Jia, Q.-Y., Yang, J.-Y., Liu, D.-J., Sun, Y.-W., Chen, P.-C., Shi, P.-D., & Chen, L. (2022). Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma. Pharmaceuticals, 15(11), 1336. https://doi.org/10.3390/ph15111336